The rapid growth of genetic epidemiology has given rise to critical commentary on the design of family studies and the analysis of family data (1) (2) (3) (4) . Recent papers have focused on estimating the contribution of environmental variables to familial aggregation of disease (5) , analyzing gene-environment interactions (6, 7) , the choice of the unit of analysis (individuals vs. family units), and the differentiation and control of age, generation, and period effects in family studies (8) (9) (10) . Some of the analytic problems that have been identified in family studies have also been identified in other types of epidemiologic studies, and methods developed elsewhere have been adapted to this type of study with little modification. Some issues, however, are uncommon in other contexts, or even unique to family data, and epidemiologic approaches cannot be applied directly. In the latter category are the issues that arise in control of confounding, the question that we address in this paper.
Familial aggregation of disease can result from aggregation of environmental risk factors (e.g., smoking, diet), genetic susceptibility, or both. In family studies that seek to assess genetic contributions to familial aggregation, familial environmental factors can have a confounding effect. In this paper, we assess strategies for control of this confounding under certain circumstances. Our analysis focuses on an intriguing question that arises in this context: Whose status with respect to the environmental factor should be controlled-the case/control (here labeled proband), the relative, or both?
As we have detailed elsewhere (4) , family studies are a true hybrid of the case-control and cohort designs, and data can be analyzed from either perspective. From a case-control perspective, one compares cases and controls in terms of the proportions with a positive family history. From a cohort perspective, on the other hand, each case defines an exposed group of relatives, and one compares the proportions affected among the exposed relatives (of cases) and the unexposed relatives (of controls). In a true casecontrol study, one would control for the confounding variable in the cases and controls. In a true cohort study, one would control for it in the exposed and unexposed groups (relatives). In a hybrid study design, either approach might be appropriate, or both, or perhaps neither.
On commonsense grounds, one might choose to control for case/control status when a case-control perspective is adopted in the analysis, and to control for the relatives' status when a cohort perspective is adopted. In practice, most contemporary studies do not follow this intuitive approach. Most use an approach that is counterintuitive but convenient; they adopt a cohort perspective in the analysis (it yields more power and allows for use of life tables), but control (if at all) for confounding on the status of the case/control (the relative's status with respect to the environmental factor is usually unknown and so cannot be controlled) (e.g., 11, 12) . A rationale for such an approach has not, to our knowledge, been developed.
We restrict attention to dichotomous environmental risk factors that aggregate in families and can increase risk for the disorder under study. Our results show that in studies of relative pairs, selection of appropriate strategies for control of confounding depends on the relation (additive, multiplicative, or other) between genotype and environment in terms of their effect on disease risk. When the relation is either additive or multiplicative, as defined below, the effect of the environmental factor can be controlled by stratifying on the status of the case/control even when the data are analyzed from a cohort perspective. However, this approach is inappropriate when the relation between genotype and environment is neither additive nor multiplicative, and unfortunately investigators seldom have information about this relation. In what follows, we describe how we arrived at this conclusion, and discuss the implications for design and analysis of family studies.
MATERIALS AND METHODS
We developed a probabilistic model to determine the joint impact of two dichotomous familial risk factors for a disorder upon familial aggregation of the disorder in pairs of relatives (e.g., parent-offspring or sib-pairs). We assumed that the two risk factors were independently distributed, i.e., occurrence of the first risk factor was not associated with occurrence of the second. However, since both risk factors were familial, occurrence of each risk factor in one relative of the pair was associated with its occurrence in the other. We also assumed that prevalence of the risk factors was equal for the two types of relatives. For an environmental factor, this corresponds to the absence of cohort or period effects that cause differences in the occurrence of the risk factors across generations or age groups. For a genetic factor, it corresponds to equal allele frequencies in the different classes of relatives. Finally, we assumed that risk of the disorder was equal for the two types of relatives, for eacfe combination of th& two risk factors. Figure 1 ilrlustrates why confounding occurs in this model, in terms of conventional epidemiologic principles. When the perspective of a cohort study is adopted, the outcome is disease in the relative, and the exposure is disease in the proband. If the environmental factor is familial and has an effect on disease risk, either the proband's status or the relative's status with respect to the environmental factor can have a confounding effect This confounding occurs because an individual's environmental risk factor status is associated with both his own disease status, and (indirectly, through familiality of the environmental factor) with his relative's disease status. Note that confounding occurs even though the two risk factors (genetic and environmental) are independently distributed. Stratification on either the proband's or the relative's environmental risk factor status removes the confounding effect by controlling for its familiality.
The risk factor to be controlled in the analysis (i.e., the environmental factor) was labelled i?i, and the risk factor whose effect on familial aggregation was being calculated (i.e., the genetic susceptibility), R 2 . The probabilities (prevalences) of the risk factors were labeled p\ and pj, respectively. The probability of disease in an individual with neither risk factor was labeled Too; in an individual with i?i but not R 2 , r i0 ; in an individual with R 2 but not Ri, r Oi ; and in an individual with both risk factors, r\ i.
In the terminology of Schlesselman (13), the multiplicative model was defined by 'biAbo = ru/rio, and the additive model by r Oi -Too = r u -r l0 . When the model was neither multiplicative nor additive, a statistical interaction was said to exist. Note that this definition of interaction is not synonymous with the concept of "gene-environment interaction" as it is sometimes used to describe biologic relations between genotype and environment (6) .
One relative in the pair was termed the "proband" and the other was termed the "relative." These designations were made without regard to disease status. Thus, both cases and controls in the usual family study are here labeled probands.
The outcome of interest was familial aggregation of disorder. In the multiplicative model, the measure of familial aggregation was termed familial aggregation relative risk (RR/), and defined as:
In the additive model, the measure of familial aggregation was termed familial aggregation risk difference (RDy), and defined as:
The joint distribution of Ri in the relative and proband was labeled m\. Thus, w,(l, 1), w,(l,0), w,(0, 1) and w,(0,0) refer to the probabilities of R { occurrence in both relative and proband, relative only, proband only, and neither, respectively. Similarly, m 2 was defined for R 2 . As shown in the example below, the joint distributions m, and m 2 may be simply derived from assumptions about the familial distribution of the risk factors R t and R 2 .
We developed formulae that allow for calculation of RR/and RD/in terms of: p\, pj, roc fio, r O i, r \u m i and m i-Th e formulae permit calculation of the "unconditional" RR/ and RD/ in the population as a whole, and of the "conditional" RR/s and RD/s in strata defined by the R\ status of proband and relative, as shown in table 1. The general formulae are given in the Appendix.
RESULTS
As shown in the Appendix, certain general relations among the "conditional" RR/s and RD/s hold. Table 1 1.00 20.41 * Assumptions: 1) environmental risk factor overall prevalence = 0.10; prevalence six tines as high in relatives of probands with the risk factor as in relatives of probands without it; 2) genetic susceptibility: autosomal dominant with aDete frequency 0.001; 3) no difference between probands and relatives m prevalence of environmental factor or genetic susceptibinty; 4) environmental risk factor and genetic susceptibility are independently distributed; 5) r u , fio, roi, roo, risks of disorder In individuals with both risk factors, environmental factor only, genetic susceptibility only, and neither, respectively; 6) RR,, famaial aggregation relative risk •= P (disease in relative| proband affected)/P (disease In relative| proband unaffected; 7) RD,, familial aggregation risk difference = P (disease in relative | proband affected) -P (disease In relative | proband unaffected). for RD/in the additive model (i.e., constancy across rows but not down columns). However, this finding does not hold when neither the multiplicative nor additive assumption is met (table l,PartC).
Below we indicate how the results illustrated in table 1 were obtained.
Example
To illustrate the results, we consider a hypothetical example. We assume that familial aggregation of disease can occur as a result of familial aggregation of an environmental risk factor (R { ) and/or genetic susceptibility (R2). The example could be conceptualized as either the effect of familial aggregation of smoking (i?i) on lung cancer familial aggregation, familial aggregation of late age at first pregnancy (R[) on breast cancer familial aggregating familial aggregation of high dietary cholesterol (R { ) on coronary heart disease familial aggregation, etc. Affected and unaffected mothers serve as case and control probands, respectively, and their daughters as the relatives. The aim is to assess familial aggregation attributable to genetic susceptibility alone. The risks and prevalences used in the example were selected for illustration only.
Prevalence of the risk factor (pi) was assumed to be 0.10, and (as noted above) was the same in both relatives. To determine the joint distribution of the risk factor in mothers and daughters (rrti), we note that prevalence of the risk factor in daughters of mothers with the risk factor = m^l, l)/pi, and prevalence in daughters of mothers without the risk factor = w,(l, 0)/(l -/?,). We also note that p x = m x (\, 1) + m x {\, 0), leading to mi(l, 0) = p\ -m x {\, 1). The risk factor was assumed to be familial, with prevalence six times as high in daughters of mothers with the risk factor as in daughters of mothers without the risk factor. This implies: The results were calculated for a multiplicative model, an additive model, and a wmodel involving statistical interaction between genotype and environment. The respective hypothetical disease risks for those with neither the genetic susceptibility nor the environmental risk factor (roo), with the risk factor but without the genetic susceptibility (r, 0 ), with the genetic susceptibility but without the risk factor (r 0) ), and with both the genetic susceptibility and the risk factor (r n ) were: in the multiplicative model, 0.001, 0.008, 0.100, and 0.800; in the additive model, 0.001, 0.008, 0.080, and 0.087; and in the interactive model, 0.001, 0.001, 0.001, and 0.800. In the interactive model, neither the genetic susceptibility nor the environmental factor had any effect in the absence of the other, but risk was increased when both were present. The measure of familial aggregation was RR/ in the multiplicative and interactive models, and RD/in the additive model.
The results are shown in table 1. These results are completely specified by the model, and hence represent true relative risks and risk differences rather than statistical estimates. Confidence intervals for the examples are therefore inapplicable.
In the multiplicative model ( In the example involving statistical interaction (table 1, part C), familial aggregation depends on presence of the environmental factor in both proband and relative.
DISCUSSION
The extent to which the observed familial aggregation of a disorder may be attributed to genes, as opposed to environment, is often controversial. We have examined dichotomous independent risk factors in probandrelative pairs. We have shown that under either the additive or multiplicative model, an environmental factor (henceforth termed Ri) can be controlled in the analysis, based only on knowledge of the R\ status of the proband. This result holds in the multiplicative model when familial aggregation is measured by a risk ratio (RR/) and in the additive model when it is measured by a risk difference (RD/). The constancy of RR/ across the first two rows of table 1, Part A provides a simple illustration of this result.
If a multiplicative or additive model can be assumed, our results simplify conduct of family studies of relative pairs considerably. In most family study designs, information on i?] in the relatives tends to be sparse or at best incomplete. Relatives may be deceased or otherwise inaccessible, the study design may not include direct assessment of relatives, and even if relatives are treated for the disorder, adequate treatment records may be difficult to obtain. Information on the probands is usually extensive, however, from direct assessment or review of treatment records or both. Therefore, the proband's Ri status is often known or at least obtainable.
Unfortunately, investigators seldom have information about the relation between genetic susceptibility and environmental risk factors in their effect on disease risk. Our results suggest that an approach could be developed for assessing this relation, by computing RR/within strata defined by both the proband's and relative's Ri status. If RR/ appears to be constant across strata of the relative's R { status, within strata of the proband's Ri status, the multiplicative model is likely to apply. Here, of course, the usual considerations with respect to sampling error will apply, and a very large sample size may be required to achieve adequate statistical power.
For some environmental risk factors, it might be reasonable to assume a multiplicative relation with genetic susceptibility. For example, individuals with alpha-1-antitrypsin deficiency, a Mendelian disorder, have increased risk of chronic obstructive pulmonary disease, and smoking markedly increases this risk (14) . However, smoking is also a potent risk factor for chronic obstructive pulmonary disease in individuals without alpha-1-antitrypsin deficiency, and the relative risks are not very different from those in deficient individuals (15) .
Nonetheless, we do not wish to impart false optimism. Examination of the relations between genetic and environmental factors is one of the most important objectives of genetic epidemiology, and this can only be fully accomplished if risk factor information is collected for relatives as well as probands.
The results in table 1 illustrate another aspect of the relation between genetic susceptibility and environmental risk factors. Under the multiplicative and additive models the degree of familial aggregation does not vary according to the relative's Ri status within strata defined by the proband's R\ status (i.e., rows are constant). However, under the additive and multiplicative models the degree of familial aggregation does vary according to the proband's Ri status. This variation may be viewed as a type of interaction, even though there is no interaction between R { and R 2 at the individual level. This interaction effect is explained in the Appendix. It occurs because of variation in the frequency of the high-risk genotype conditional on the proband's R t and disease status. In fact, even an environmental risk factor that causes the disease but is not a confounder (i.e., is nonfamilial) creates this type of interaction.
Under the multiplicative model, RR/ is always higher when the proband has the risk factor than when she does not. This is because the multiplicative assumption implies that the frequency of the high-risk genotype is the same among cases with and without i?i, but the frequency of the high-risk genotype is lower among controls with Ri than among controls without R t . (That is, a person who manages to escape having the disease despite having the risk factor is less likely to be genetically susceptible than is one who escapes disease but does not have the risk factor.) However, our results with many other numerical examples suggest that in the multiplicative model, the difference in RR/between probands with and without Ri is generally very small, as in table 1, unless both the genetic and environmental factors have very large effects on disease risk.
It is not immediately apparent which of the conditional RR/s and RD/s represents the sole effect of genetic susceptibility on familial aggregation of disorder. When the confounding effect of the relative's R { status is removed by removing its association with disorder (i.e., by setting r n = r O i and no = roo), RR/and RD/are equal to the RR/and RD/ obtained in the strata where the proband does not have Ri. Thus, this value would seem a logical choice to represent the sole effect of genetic susceptibility. However, when the confounding effect of the relative's Ri status is removed by making it nonfamilial, RR/ and RD/ still vary across strata of the proband's Rt status because of interaction (see above). These results follow readily from application of the general formulae in the Appendix.
Our results not only clarify control of environmental risk factors in family studies, but also underscore the need to do so. In the example in table 1, an important difference between the crude and stratified RR/s was observed (12.03 vs. 7.86). Moreover, as is generally true in epidemiologic studies, the presence of multiple confounding variables will magnify this difference considerably.
Some family studies may seek to establish that an environmental factor (e.g., infection) is involved in causation of a disorder, by demonstrating familial aggregation of the disorder. In these studies, the control of confounding by genetic factors is also resolved in theory, but not in practice. To accomplish such control, R { would be defined as the genetic susceptibility, but in most cases stratification on the proband's Ri status is impossible because the relevant genetic susceptibility cannot be measured.
Finally, we wish to emphasize that this paper represents only a first step toward clarification of the several amgibuities in analytic method in family studies that we have described elsewhere (4). In the model presented here, the impact of R { on disease familial aggregation is entirely indirect-the proband's Ri status influences the relative's risk only through familial aggregation ofRi. If the proband's R { status had a direct effect on the relative's risk (such as with passive smoking), different results would be expected. Our probabilistic model also needs to be extended to more complex conditions, in which there are multiple relatives rather than proband-relative pairs, nonindependent and/or nondichotomous risk factors, and multiple familial environmental risk factors. Finally, control of variables with special properties, such as age, sex, and family size, needs to be addressed in future work.
APPENDIX
We develop a probability model to enable calculation of the joint impact of two independent dichotomous familial risk factors on the familial aggregation of a disorder in pairs of relatives. In the development below some elementary knowledge of probability theory, as well as familiarity with matrix-vector notation and manipulation, is assumed.
A. GENERAL MODEL

Single individual
We start with the simple model corresponding to a single individual. We consider the case of a disorder, D, and two "risk factors," R u R 2 . Each of these may assume only two values, 0 = absent or 1 = present. The sample space consists of three tuples, where the first two entries are risks present or absent, for R { and R 2 , respectively, and the third entry is disorder present or absent. Thus, the sample space consists of eight points, referred to as elementary events denoted as (Ri, R 2 , D) , where each component is 1 or 0. In a more generic notation, each elementary event can be denoted (i,j, d ).
We define a probability measure on this sample space such that the risks R\ and R 2 are independent. We require that the measure satisfy P{R\ = 1) = Pi, P(R 2 = 1) = P2, where p u Pi are the prevalences of risk factors R\ and R 2 , respectively. Let express the probability distribution of a binary variable, say, Z, such that P(Z = 1) = p and />(Z = 0) = 1 -p.
We define the quantities r l} as conditional probabilities of the disorder given the presence or absence of risks R t and R 2 , e.g.,
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Using this definition and the notation above we define a probability measure on the sample space by the equation
Since the quantities i, j, d are binary only a single term appears for each component; thus, P{\, 0, 0) = p\(\ -P2XI -Ho). Equation A-l assigns a probability to the elementary events, which allows the probability of any event to be determined. Thus, P{R X = _, R 2 = 1, D = Using the preceding expression and the definition of conditional probability, we have The quantity RR 2 is referred to as the relative risk of D due to i? 2 -
Pairs of related individuals
In order to build a probability space for two individuals, a proband and a relative, an elementary event may be represented as a six tuple, say, (k, I, A, /' , j, d), where the first three entries represent the relative's status and the last three the status of the proband. For example, the outcome (011 100) in the sample space may be interpreted as, the relative has risk factor 1 absent, and risk factor 2 present and has the disorder, the proband has risk factor 1 present and risk factor 2 absent and is disorder free. We assume that the prevalence of both risk factors is the same for the proband as for the relative. We define two joint probability measures rri\(k, i) and m 2 (l, j) to reflect the familial dependence for each risk factor, respectively. Thus, m,(l, 0) is the probability that risk factor 1 is present in the relative and absent in the proband. Since the marginals are forced to be equal, i.e., mi(l, 0) + rri\(l, 1) = Wi(0, 1) + mi(\, 1) = p u m\{k, i) is a symmetric probability measure, i.e., m.\(\, 0) = /«i(0, 1). The measure w 2 (/, j) is similarly symmetric. We define a probability measure on the sample space by the equation
This model is determined by specifying the four quantities, roo, r 0l , r 10 , and r M and the two joint probability measures ni\(k, i) and m 2 (/, j). The probabilistic model given in equation A-3 implies that 1) the risk factors, R { and R 2 , are independent, and 2) the probabilistic dependence of disorder between a proband and relative enters only via the dependence on each of the two risk factors. When an event concerns only the relative or only the proband, equation A-3 simplifies to equation A-l, as this is the "marginal" of equation A-3 in the first three or last three components. We introduce matrix-vector notation. Let r, = (r u , r, 0 )', and r 0 = (r O i, roo)' be the 2 x 1 vectors whose components are the disease risks for both risk factors. Let M 2 be the 2 x 2 symmetric matrix The arguments above enable one to write the risks of the previous expression as roM 2 r t / Z'M 2 r u and as r'oM 2 {^ -r\)/^'M 2 {^ -r,). The ratio of these risks is RR/and the difference isRDr.
The row labeled Tin Appendix table 1 disregards R\ for the proband. That is, the entries in the row labeled T{i not specified) and column R x = 1 are the conditional risks, P(A = l|fc= 1, d= l)andP(A= l\k= 1, ^ = 0).
Similarly, the column labeled T disregards R[ in the relative.
The entries in the third row, third column are defined as the corresponding risks, P(A = \\d= l)andP(A = \\d = 0).
A similar table holding for the risk factor R 2 is obtained by replacing M 2 by M\ and defining f\ = (rii, r Oi y, and r 0 = (r l0 , Too)'.
B. MULTIPLICATIVE MODEL
In the multiplicative model, for a given R { in the proband, the RR/s formed from the ratio of the entries in Appendix table 1, are the same in each column. That is, for a given risk factor status of the proband the RR/does not depend on the risk factor status of the relative. • Two conditional risks, separated by a semicolon, appear in each cell, P(A = 1 \d » 1) and P(A = 1 \d = 0). Each of these is conditioned by the fl, status of the proband and relative defining that cell.
